Presentation
19 April 2017 New chemical probe technologies: applications to imaging and drug discovery (Conference Presentation)
Matthew Bogyo
Author Affiliations +
Abstract
Proteases are enzymes that play pathogenic roles in many common human diseases such as cancer, asthma, arthritis, atherosclerosis and infection by pathogens. Tools to dynamically monitor their activity can be used as diagnostic agents, as imaging contrast agents for intra-operative image guidance and for the identification of novel classes of protease-targeted drugs. I will describe our efforts to design and synthesize small molecule probes that produce a fluorescent signal upon binding to a protease target. We have identified probes that show tumor-specific retention, fast activation kinetics, and rapid systemic distribution making them useful for real-time fluorescence guided tumor resection and other diagnostic imaging applications.
Conference Presentation
© (2017) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Matthew Bogyo "New chemical probe technologies: applications to imaging and drug discovery (Conference Presentation)", Proc. SPIE 10049, Molecular-Guided Surgery: Molecules, Devices, and Applications III, 100490N (19 April 2017); https://doi.org/10.1117/12.2257636
Advertisement
Advertisement
KEYWORDS
Diagnostics

Drug discovery

Pathogens

Tumors

Molecules

Cancer

Imaging systems

Back to Top